Analysis of the incidence of new coronavirus infection in oncological patients on the example of the oncological department of anticancer drug therapy of the Bashkir State Medical University


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Follow-up of oncological patients with coronavirus infection requires careful monitoring. Currently, there is no reliable national statistics on morbidity among patients with oncopathologies, as well as information on the features of the course of the disease. In our opinion, such an exchange of information is extremely important in order to properly organize work in the context of the COVID-19 pandemic.

全文:

受限制的访问

作者简介

N. Yuldasheva

Bashkir State Medical University, BSMU Clinic

Ufa, Russia

Regina Kunafina

Bashkir State Medical University, BSMU Clinic

Email: kunafinareg2017@yandex.ru
Oncologist, Head of the Department of Chemotherapy 2, Shafieva str., Ufa 450059, Russian Federation

D. Sakaeva

Bashkir State Medical University, BSMU Clinic

Ufa, Russia

D. Baikov

Bashkir State Medical University, BSMU Clinic

Ufa, Russia

R. Suleymanova

Bashkir State Medical University, BSMU Clinic

Ufa, Russia

参考

  1. Сперанская А.А. Лучевые проявления новой коронавирусной инфекции COVID-19. Лучевая диагностика и терапия. 2020;11(1):18-25.
  2. Каприн А.Д., Гамеева Е.В., Поляков А.А. и др. Влияние пандемии COVID-19 на онкологическую практику. Сибирский онкологический журнал. 2020;19(3):5-22.
  3. Практические рекомендации Российского общества клинической онкологии по оказанию онкологической помощи в условиях пандемии COVID-19. Интернет портал Российского общества клинической онкологии. 2020. URL: https:// rosoncoweb.ru/standarts/COVID-19/ (дата обращения 18.09.2020).

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2020
##common.cookie##